Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Says FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted For Review By USFDA

BRIEF-Zydus Lifesciences Says FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted For Review By USFDA

- Zydus Lifesciences Ltd ZYDU.NS:

  • FYB206 BECOMES FIRST PUBLICLY ANNOUNCED KEYTRUDA BIOSIMILAR ACCEPTED FOR REVIEW BY USFDA


Further company coverage: ZYDU.NS


((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Zydus Lifesciences

See all news